{"id":"https://openalex.org/W4241554814","doi":"https://doi.org/10.1158/1538-7445.sabcs18-4741","title":"Abstract 4741: Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies","display_name":"Abstract 4741: Re-evaluating the role of P-glycoprotein in the resistance of high-risk neuroblastoma to standard-of-care chemotherapies","publication_year":2019,"publication_date":"2019-07-01","ids":{"openalex":"https://openalex.org/W4241554814","doi":"https://doi.org/10.1158/1538-7445.sabcs18-4741"},"language":"en","primary_location":{"id":"doi:10.1158/1538-7445.sabcs18-4741","doi":"https://doi.org/10.1158/1538-7445.sabcs18-4741","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-4741","pdf_url":null,"source":{"id":"https://openalex.org/S4306510252","display_name":"Experimental and Molecular Therapeutics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Molecular Therapeutics","raw_type":"proceedings-article"},"volume":null,"type":"conference-abstract","indexed_in":["crossref"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":null,"display_name":"Caroline Atkinson","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Caroline Atkinson","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009873158","display_name":"Carole M. Tactacan","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Carole M. Tactacan","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5006270132","display_name":"Alvin Kamili","orcid":"https://orcid.org/0000-0002-4864-1195","observed_orcids":["https://orcid.org/0000-0002-4864-1195"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Alvin Kamili","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082316302","display_name":"Federica Saletta","orcid":"https://orcid.org/0000-0003-0598-3504","observed_orcids":["https://orcid.org/0000-0003-0598-3504"]},"institutions":[{"id":"https://openalex.org/I2802384191","display_name":"Children's Hospital at Westmead","ror":"https://ror.org/05k0s5494","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I2802384191"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Federica Saletta","raw_affiliation_strings":["Children's Cancer Research Unit, Westmead, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Research Unit, Westmead, Australia","institution_ids":["https://openalex.org/I2802384191"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030864022","display_name":"Christine C. Gana","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Christine Gana","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067193371","display_name":"Georgina L. Eden","orcid":"https://orcid.org/0000-0003-4593-0028","observed_orcids":["https://orcid.org/0000-0003-4593-0028"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Georgina L. Eden","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053765299","display_name":"Chelsea Mayoh","orcid":"https://orcid.org/0000-0002-6398-3046","observed_orcids":["https://orcid.org/0000-0002-6398-3046"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Chelsea Mayoh","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5028049853","display_name":"Richard B. Lock","orcid":"https://orcid.org/0000-0002-3436-9071","observed_orcids":["https://orcid.org/0000-0002-3436-9071"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Richard B. Lock","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5011765291","display_name":"Murray D. Norris","orcid":"https://orcid.org/0000-0002-0632-4589","observed_orcids":["https://orcid.org/0000-0002-0632-4589"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Murray D. Norris","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5072009574","display_name":"Michelle Haber","orcid":"https://orcid.org/0000-0003-2036-8817","observed_orcids":["https://orcid.org/0000-0003-2036-8817"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Michelle Haber","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5053799594","display_name":"Andrew J. Gifford","orcid":"https://orcid.org/0000-0002-4092-2347","observed_orcids":["https://orcid.org/0000-0002-4092-2347"]},"institutions":[{"id":"https://openalex.org/I4210108821","display_name":"Prince of Wales Hospital","ror":"https://ror.org/022arq532","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210108821"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Andrew J. Gifford","raw_affiliation_strings":["Prince of Wales Hospital, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Prince of Wales Hospital, Randwick, Australia","institution_ids":["https://openalex.org/I4210108821"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5022402043","display_name":"Toby N. Trahair","orcid":"https://orcid.org/0000-0002-3295-228X","observed_orcids":["https://orcid.org/0000-0002-3295-228X"]},"institutions":[{"id":"https://openalex.org/I4210125633","display_name":"Sydney Children's Hospital","ror":"https://ror.org/02tj04e91","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210125633","https://openalex.org/I4210149013"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Toby N. Trahair","raw_affiliation_strings":["Sydney Children\u2019s Hospital, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Sydney Children\u2019s Hospital, Randwick, Australia","institution_ids":["https://openalex.org/I4210125633"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5086653157","display_name":"Jamie I. Fletcher","orcid":"https://orcid.org/0000-0003-2949-9469","observed_orcids":["https://orcid.org/0000-0003-2949-9469"]},"institutions":[{"id":"https://openalex.org/I4210112315","display_name":"Children's Cancer Institute Australia","ror":"https://ror.org/01x784220","country_code":"AU","type":"healthcare","lineage":["https://openalex.org/I4210112315"]}],"countries":["AU"],"is_corresponding":false,"raw_author_name":"Jamie I. Fletcher","raw_affiliation_strings":["Children's Cancer Institute, Randwick, Australia"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Children's Cancer Institute, Randwick, Australia","institution_ids":["https://openalex.org/I4210112315"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":4,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":null,"has_fulltext":false,"cited_by_count":0,"citation_normalized_percentile":null,"cited_by_percentile_year":null,"biblio":{"volume":null,"issue":null,"first_page":"4741","last_page":"4741"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T12226","display_name":"Neuroblastoma Research and Treatments","score":0.5976999998092651,"subfield":{"id":"https://openalex.org/subfields/2728","display_name":"Clinical Neurology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10570","display_name":"Drug Transport and Resistance Mechanisms","score":0.39579999446868896,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10147","display_name":"Antibiotic Resistance in Bacteria","score":0.0005000000237487257,"subfield":{"id":"https://openalex.org/subfields/1313","display_name":"Molecular Medicine"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/p-glycoprotein","display_name":"P-glycoprotein","score":0.9760000109672546},{"id":"https://openalex.org/keywords/high-risk-neuroblastoma","display_name":"high-risk neuroblastoma","score":0.9819999933242798},{"id":"https://openalex.org/keywords/chemoresistance","display_name":"chemoresistance","score":0.6919999718666077},{"id":"https://openalex.org/keywords/multidrug-efflux-transporter","display_name":"multidrug efflux transporter","score":0.777999997138977},{"id":"https://openalex.org/keywords/tariquidar","display_name":"tariquidar","score":0.8640000224113464},{"id":"https://openalex.org/keywords/p-glycoprotein-inhibitors","display_name":"P-glycoprotein inhibitors","score":0.7739999890327454},{"id":"https://openalex.org/keywords/vincristine","display_name":"vincristine","score":0.8379999995231628},{"id":"https://openalex.org/keywords/doxorubicin","display_name":"doxorubicin","score":1.0},{"id":"https://openalex.org/keywords/etoposide","display_name":"etoposide","score":1.0},{"id":"https://openalex.org/keywords/alk-inhibitors","display_name":"ALK inhibitors","score":0.8410000205039978},{"id":"https://openalex.org/keywords/crizotinib","display_name":"crizotinib","score":0.9679999947547913},{"id":"https://openalex.org/keywords/patient-derived-xenografts","display_name":"patient-derived xenografts","score":0.9620000123977661},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.8420000076293945}],"concepts":[{"id":"https://openalex.org/C2776715637","wikidata":"https://www.wikidata.org/wiki/Q938205","display_name":"Neuroblastoma","level":3,"score":0.6884536743164062},{"id":"https://openalex.org/C2778707650","wikidata":"https://www.wikidata.org/wiki/Q412902","display_name":"P-glycoprotein","level":4,"score":0.6144073009490967},{"id":"https://openalex.org/C2993769353","wikidata":"https://www.wikidata.org/wiki/Q7598360","display_name":"Standard of care","level":2,"score":0.4864606559276581},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.4671829044818878},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.366426557302475},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.35179653763771057},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.3292689323425293},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.3208900988101959},{"id":"https://openalex.org/C133936738","wikidata":"https://www.wikidata.org/wiki/Q643839","display_name":"Multiple drug resistance","level":3,"score":0.20828396081924438},{"id":"https://openalex.org/C114851261","wikidata":"https://www.wikidata.org/wiki/Q12147416","display_name":"Drug resistance","level":2,"score":0.19831028580665588},{"id":"https://openalex.org/C86803240","wikidata":"https://www.wikidata.org/wiki/Q420","display_name":"Biology","level":0,"score":0.18329793214797974},{"id":"https://openalex.org/C54355233","wikidata":"https://www.wikidata.org/wiki/Q7162","display_name":"Genetics","level":1,"score":0.1021166741847992},{"id":"https://openalex.org/C81885089","wikidata":"https://www.wikidata.org/wiki/Q189082","display_name":"Cell culture","level":2,"score":0.0}],"mesh":[],"locations_count":1,"locations":[{"id":"doi:10.1158/1538-7445.sabcs18-4741","doi":"https://doi.org/10.1158/1538-7445.sabcs18-4741","is_oa":false,"landing_page_url":"https://doi.org/10.1158/1538-7445.sabcs18-4741","pdf_url":null,"source":{"id":"https://openalex.org/S4306510252","display_name":"Experimental and Molecular Therapeutics","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Experimental and Molecular Therapeutics","raw_type":"proceedings-article"}],"best_oa_location":null,"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":0,"referenced_works":[],"related_works":["https://openalex.org/W3047585484","https://openalex.org/W4416041288","https://openalex.org/W2218189347","https://openalex.org/W1984529434","https://openalex.org/W2041209857","https://openalex.org/W4298326926","https://openalex.org/W6941357967","https://openalex.org/W2583632285","https://openalex.org/W2523341158","https://openalex.org/W2354988938"],"abstract_inverted_index":{"Background:":[0],"Neuroblastoma":[1],"is":[2,126,143,155,175,231],"the":[3,62,84,146,150,189,321,326,338],"most":[4,162],"common":[5,157,232],"extracranial":[6],"solid":[7],"malignancy":[8],"in":[9,50,71,92,128,134,158,161,172,233,245,325],"children,":[10],"comprising":[11],"15%":[12],"of":[13,29,86,111,131,149,170,272,323,328,337],"cancer":[14],"related":[15],"deaths.":[16],"Despite":[17],"intensive":[18],"treatment,":[19],"patients":[20],"with":[21,177,181],"high-risk":[22,329],"neuroblastoma":[23,112,204,221,330],"(HR-NB)":[24],"have":[25],"a":[26],"survival":[27],"rate":[28],"~50%,":[30],"largely":[31],"due":[32],"to":[33,82,94,145,206,213,223,239,242,258,266,277,331],"intrinsic":[34],"or":[35],"acquired":[36],"drug":[37],"resistance.":[38],"The":[39,270],"multidrug":[40,183],"transporter":[41,184],"P-glycoprotein":[42,324],"(P-gp;":[43],"ABCB1)":[44],"effluxes":[45],"several":[46],"conventional":[47,278],"agents":[48],"used":[49,257],"HR-NB":[51,72,159,173,234,281],"induction":[52],"therapy,":[53],"including":[54],"doxorubicin,":[55],"vincristine":[56],"and":[57,75,89,97,101,106,117,165,193,209,235,265],"etoposide,":[58],"as":[59,61,275],"well":[60],"ALK":[63,214],"inhibitor":[64,191],"crizotinib.":[65],"We":[66,186],"observed":[67],"high":[68,123,141,153,167,201],"P-gp":[69,87,190,194,202,217,229,253,273],"expression":[70,88,125,142,154,169,230],"cell":[73,118],"lines":[74],"patient-derived":[76],"xenograft":[77],"(PDX)":[78],"models,":[79],"so":[80],"sought":[81],"assess":[83],"prevalence":[85],"its":[90,182],"role":[91,322],"resistance":[93,241,327],"standard-of-care":[95,243,332],"chemotherapies":[96,244,333],"relevant":[98],"targeted":[99],"agents.Methods":[100],"Results:":[102],"Using":[103],"RNA-sequencing,":[104],"immunohistochemistry":[105],"western":[107],"blot":[108],"on":[109],"panels":[110],"tumour":[113,252],"samples,":[114],"PDX":[115],"models":[116],"lines,":[119],"we":[120],"demonstrated":[121,187],"that":[122,140,152,166,188,251],"ABCB1/P-gp":[124],"frequent":[127],"HR-NB.":[129],"Analysis":[130],"ABCB1":[132,171],"levels":[133,254],"large":[135],"patient":[136],"tumor":[137],"datasets":[138],"suggests":[139],"attributable":[144],"sympathoadrenal":[147],"lineage":[148],"disease,":[151],"more":[156],"than":[160],"other":[163],"cancers,":[164],"relative":[168],"tumours":[174],"associated":[176],"poorer":[178],"outcome,":[179],"consistent":[180],"function.":[185],"tariquidar":[192],"knockdown":[195,218],"(shRNA)":[196],"both":[197],"strongly":[198],"sensitize":[199],"cultured":[200],"expressing":[203],"cells":[205],"vincristine,":[207,224],"doxorubicin":[208],"etoposide":[210],"but":[211],"not":[212],"inhibitors.":[215],"Further,":[216],"sensitized":[219],"human":[220],"xenografts":[222],"substantially":[225],"extending":[226],"survival.Conclusions:":[227],"Elevated":[228],"can":[236],"be":[237,256,283],"sufficient":[238],"confer":[240],"model":[246],"systems.":[247],"Our":[248],"findings":[249],"suggest":[250],"might":[255],"guide":[259],"treatment":[260],"options":[261],"for":[262,280,341],"individual":[263],"patients,":[264],"avoid":[267],"ineffective":[268],"treatments.":[269],"potential":[271],"inhibitors":[274],"adjuncts":[276],"chemotherapy":[279],"should":[282],"further":[284],"investigated.Citation":[285],"Format:":[286],"Caroline":[287],"Atkinson,":[288],"Carole":[289],"M.":[290],"Tactacan,":[291],"Alvin":[292],"Kamili,":[293],"Federica":[294],"Saletta,":[295],"Christine":[296],"Gana,":[297],"Georgina":[298],"L.":[299],"Eden,":[300],"Chelsea":[301],"Mayoh,":[302],"Richard":[303],"B.":[304],"Lock,":[305],"Murray":[306],"D.":[307],"Norris,":[308],"Michelle":[309],"Haber,":[310],"Andrew":[311],"J.":[312],"Gifford,":[313],"Toby":[314],"N.":[315],"Trahair,":[316],"Jamie":[317],"I.":[318],"Fletcher.":[319],"Re-evaluating":[320],"[abstract].":[334],"In:":[335],"Proceedings":[336],"American":[339],"Association":[340],"Cancer":[342,356],"Research":[343],"Annual":[344],"Meeting":[345],"2019;":[346],"2019":[347],"Mar":[348],"29-Apr":[349],"3;":[350],"Atlanta,":[351],"GA.":[352],"Philadelphia":[353],"(PA):":[354],"AACR;":[355],"Res":[357],"2019;79(13":[358],"Suppl):Abstract":[359],"nr":[360],"4741.":[361]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-05-12T00:00:00"}